These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 34229673)

  • 1. Up and down waves of glycemic control and lower-extremity amputation in diabetes.
    Caruso P; Scappaticcio L; Maiorino MI; Esposito K; Giugliano D
    Cardiovasc Diabetol; 2021 Jul; 20(1):135. PubMed ID: 34229673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does Perioperative Hemoglobin A1c Level Affect the Incidence, Pattern and Mortality of Lower Extremity Amputation?
    Al-Thani H; El-Matbouly M; Al-Sulaiti M; Al-Thani N; Asim M; El-Menyar A
    Curr Vasc Pharmacol; 2019; 17(4):354-364. PubMed ID: 29359671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Neuropathy, Glycemic Control, and Revascularization as Risk Factors for Future Lower Extremity Amputation among Diabetic Patients.
    Goldman MP; Corriere MA; Craven T; Davis RP; Sheehan M; Hurie JB; Velazquez G; Williams TK; Chang K; Edwards MS
    Ann Vasc Surg; 2021 May; 73():254-263. PubMed ID: 33248240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of preprocedural glycemic control on clinical outcomes of endovascular therapy in diabetic patients with lower extremity artery disease: an analysis from a Korean multicenter retrospective registry cohort.
    Cha JJ; Kim H; Ko YG; Choi D; Lee JH; Yoon CH; Chae IH; Yu CW; Lee SW; Lee SR; Choi SH; Koh YS; Min PK;
    Cardiovasc Diabetol; 2020 Jun; 19(1):97. PubMed ID: 32571352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High hemoglobin A
    Arya S; Binney ZO; Khakharia A; Long CA; Brewster LP; Wilson PW; Jordan WD; Duwayri Y
    J Vasc Surg; 2018 Jan; 67(1):217-228.e1. PubMed ID: 28844470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Intensive Glycemic Control on Risk of Lower Extremity Amputation.
    Goldman MP; Clark CJ; Craven TE; Davis RP; Williams TK; Velazquez-Ramirez G; Hurie JB; Edwards MS
    J Am Coll Surg; 2018 Dec; 227(6):596-604. PubMed ID: 30336205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presentations of major peripheral arterial disease and risk of major outcomes in patients with type 2 diabetes: results from the ADVANCE-ON study.
    Mohammedi K; Woodward M; Hirakawa Y; Zoungas S; Colagiuri S; Hamet P; Harrap S; Poulter N; Matthews DR; Marre M; Chalmers J;
    Cardiovasc Diabetol; 2016 Sep; 15(1):129. PubMed ID: 27590190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Traditional and nontraditional glycemic markers and risk of peripheral artery disease: The Atherosclerosis Risk in Communities (ARIC) study.
    Ding N; Kwak L; Ballew SH; Jaar B; Hoogeveen RC; Ballantyne CM; Sharrett AR; Folsom AR; Heiss G; Salameh M; Coresh J; Hirsch AT; Selvin E; Matsushita K
    Atherosclerosis; 2018 Jul; 274():86-93. PubMed ID: 29753232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes following Lower Extremity Amputation in Patients with Diabetes Mellitus and Peripheral Arterial Disease.
    Pourghaderi P; Yuquimpo KM; Roginski Guetter C; Mansfield L; Park HS
    Ann Vasc Surg; 2020 Feb; 63():259-268. PubMed ID: 31626926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Outcomes in Patients With Type 2 Diabetes Mellitus and Peripheral Artery Disease: Results From the EXSCEL Trial.
    Badjatiya A; Merrill P; Buse JB; Goodman SG; Katona B; Iqbal N; Pagidipati NJ; Sattar N; Holman RR; Hernandez AF; Mentz RJ; Patel MR; Jones WS
    Circ Cardiovasc Interv; 2019 Dec; 12(12):e008018. PubMed ID: 31752517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenges and opportunities in the management of type 2 diabetes in patients with lower extremity peripheral artery disease: a tailored diagnosis and treatment review.
    Mahé G; Aboyans V; Cosson E; Mohammedi K; Sarlon-Bartoli G; Lanéelle D; Mirault T; Darmon P
    Cardiovasc Diabetol; 2024 Jun; 23(1):220. PubMed ID: 38926722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poor glycemic control is associated with significant increase in major limb amputation and adverse events in the 30-day postoperative period after infrainguinal bypass.
    McGinigle KL; Kindell DG; Strassle PD; Crowner JR; Pascarella L; Farber MA; Marston WA; Arya S; Kalbaugh CA
    J Vasc Surg; 2020 Sep; 72(3):987-994. PubMed ID: 32139308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of micro- and macro-vascular disease and Tumor Necrosis Factor Receptor 1 on the level of lower-extremity amputation in patients with type 2 diabetes.
    Schneider F; Saulnier PJ; Gand E; Desvergnes M; Lefort N; Thorin E; Thorin-Trescases N; Mohammedi K; Ragot S; Ricco JB; Hadjadj S
    Cardiovasc Diabetol; 2018 Jun; 17(1):81. PubMed ID: 29879997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of complication following lower extremity amputation in diabetic end-stage renal disease.
    Park YH; Song JH; Choi GW; Kim HJ
    Nephrology (Carlton); 2018 Jun; 23(6):518-522. PubMed ID: 28444845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative hemoglobin A1c levels and increased risk of adverse limb events in diabetic patients undergoing infrainguinal lower extremity bypass surgery in the Vascular Quality Initiative.
    Singh N; Zeng C; Lewinger JP; Wolfson AM; Shavelle D; Weaver F; Garg PK
    J Vasc Surg; 2019 Oct; 70(4):1225-1234.e1. PubMed ID: 30852042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temporal changes in the prevalence and associates of diabetes-related lower extremity amputations in patients with type 2 diabetes: the Fremantle Diabetes Study.
    Baba M; Davis WA; Norman PE; Davis TM
    Cardiovasc Diabetol; 2015 Dec; 14():152. PubMed ID: 26684912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initiation of SGLT2 Inhibitors and the Risk of Lower Extremity Minor and Major Amputation in Patients with Type 2 Diabetes and Peripheral Arterial Disease: A Health Claims Data Analysis.
    Rodionov RN; Peters F; Marschall U; L'Hoest H; Jarzebska N; Behrendt CA
    Eur J Vasc Endovasc Surg; 2021 Dec; 62(6):981-990. PubMed ID: 34782230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lower extremity amputation in peripheral artery disease: improving patient outcomes.
    Swaminathan A; Vemulapalli S; Patel MR; Jones WS
    Vasc Health Risk Manag; 2014; 10():417-24. PubMed ID: 25075192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetic phenotype and prognosis of patients with heart failure and preserved ejection fraction in a real life cohort.
    Lejeune S; Roy C; Slimani A; Pasquet A; Vancraeynest D; Vanoverschelde JL; Gerber BL; Beauloye C; Pouleur AC
    Cardiovasc Diabetol; 2021 Feb; 20(1):48. PubMed ID: 33608002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemoglobin A1c Testing and Amputation Rates in Black, Hispanic, and White Medicare Patients.
    Suckow BD; Newhall KA; Bekelis K; Faerber AE; Gottlieb DJ; Skinner JS; Stone DH; Goodney PP
    Ann Vasc Surg; 2016 Oct; 36():208-217. PubMed ID: 27474195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.